149144-05-8

Basic information

• Product Name: 3-CHLORO-4.5-DIFLUOROANILINE
• Synonyms: 3-CHLORO-4.5-DIFLUOROANILINE
• CAS NO: 149144-05-8
• Molecular Formula: C₆H₄ClF₂N
• Molecular Weight: 163.5524664
• Mol File: 149144-05-8.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-CHLORO-4.5-DIFLUOROANILINE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-CHLORO-4.5-DIFLUOROANILINE(149144-05-8)
• EPA Substance Registry System: 3-CHLORO-4.5-DIFLUOROANILINE(149144-05-8)

Safety Data

• Hazardous Substances Data: 149144-05-8(Hazardous Substances Data)

Upstream product

• 150444-95-4 3-chloro-4,5-difluorobenzoic acid 
• 1572516-19-8 tert-butyl N-(3-chloro-4,5-difluoro-phenyl)carbamate 
• 1572516-21-2 3-chloro-4,5-difluoroaniline hydrochloride 
• 53780-44-2 1-Chloro-2,3-difluoro-5-nitrobenzene 

Downstream Products

• 1437779-47-9 5-(5-(3-chloro-4,5-difluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-3,3-dimethylbenzo[c][1,2]oxaborol-1(3H)-ol 
• 1060813-07-1 5-bromo-1-chloro-2,3-difluorobenzene 
• 1437779-87-7 2-(3-chloro-4,5-difluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
• 1572513-53-1 N-(3-chloro-4,5-difluorophenyl)-2-fluoro-6-methyl-3-[[(1R)-2,2,2-trifluoro-1-methylethyl]sulfamoyl]benzamide 
• 1572516-24-5 5-bromo-N-(3-chloro-4,5-difluorophenyl)-2-fluoro-6-methyl-3-[[(1R)-2,2,2-trifluoro-1-methylethyl]sulfamoyl]benzamide 
• 1573008-96-4 5-bromo-3-[(3-chloro-4,5-difluorophenyl)carbamoyl]-2-fluoro-4-methylbenzenesulfonyl chloride 

Relevant articles and documents

SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

Inhibitors of HBV replication of Formula (I) including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein B, R1, R2 and R4 have the meaning as defined herein. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HBV inhibitors, in HBV therapy.

SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

Inhibitors of HBV replication of Formula (I) including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein B, R1, R2 and R4 have the meaning as defined herein. The present invention also relates to pharmaceutical compositions containing these inhibitors and to their use, alone or in combination with other HBV inhibitors, in HBV therapy.

SULPHAMOYLTHIOPHENAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

Inhibitors of HBV replication of formula (I) including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein X and R1 to R8 have the meaning as defined herein. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HBV inhibitors, in HBV therapy.

SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

Inhibitors of HBV replication of Formula (ID) including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein X, Ra to Rd and R4 to R6 have the meaning as defined herein. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HBV inhibitors, in HBV therapy.

BORON-CONTAINING SMALL MOLECULES

This invention provides novel compounds, methods of using the compounds, and pharmaceutical formulations comprising the compounds.

HEPATITIS B ANTIVIRAL AGENTS

The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.